Bristol Myers Seeks Expanded Approval for CAR-T Cell Therapy
Bristol Myers Squibb, a biopharmaceutical company based in Princeton, N.J., has recently been granted priority review by the U.S. Food and Drug Administration (FDA) for two applications related to the…